Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Nath Bio-Genes (India) Ltd

| Q2 & H1 FY26 Earnings Conference Call

NEUTRAL SENTIMENT

Report Source

14th Nov 25

Summary : Nath Bio-Genes demonstrates resilience and growth despite climate challenges, driven by R&D and diversification, but faces issues from illegal seeds and margin pressures.

Management Perspective positive : Friends, the first half of financial year '26 has been a period that truly tested the resilience of Indian agriculture and also reaffirmed the strength of Nath Bio-Genes. Despite uneven monsoons, erratic rainfall and evolving market dynamics, our teams on the ground have continued to deliver consistent results and strengthen farmer trust in our products. With a resilient portfolio, expanding international presence and a farmer-first mission, Nath Bio-Genes stands well positioned to deliver sustained growth and value creation in the years ahead.

Concall Report Analysis & Insights

Business Overview

  1. H1 FY'26 revenue grew 15.9% Y-o-Y to INR3,199 million, with gross profit up 21.3%.
  2. Cotton business volume grew 6% Y-o-Y, value grew 26.3%, supported by premium products.
  3. Maize showed a sharp recovery with double-digit growth due to favorable conditions.
  4. Vegetable seeds emerged as the fastest-growing segment, with 25% Y-o-Y value growth.
  5. Plant Nutrition Solutions (PNS) sustained growth momentum, reflecting its importance.

Future Growth Prospects

  1. Focused on diversification beyond cotton and accelerating high-margin product growth.
  2. Strong R&D pipeline with promising hybrids identified for commercial introduction.
  3. Uzbekistan joint venture progressing well, strengthening international footprint.
  4. Expect 15% revenue growth for H2 FY'26 and 15-20% for FY'27.
  5. Developing superior, unique products across all segments to enhance value.

Management Insights

  1. Management emphasized resilience despite challenging climate and market dynamics.
  2. Committed to empowering farmers with seeds and technology for good yields.
  3. R&D and product development are key to enhancing portfolio and disease resistance.
  4. Focused on quality, farmer satisfaction, and timely product placement to minimize returns.
  5. Prepared for market shifts and contingencies, planning 6 months in advance.

Signs of Skepticism

  1. An individual investor questioned the lack of wealth generation for shareholders, which management dismissed as not their concern.

Risk Factors

  1. Indian agriculture tested by uneven monsoons and erratic rainfall.
  2. Industry impacted by the spread of illegal BT cotton and RRF cotton.
  3. Bajra segment saw moderate decline due to lower acreages and softer rural sentiment.
  4. Working capital increased significantly due to higher receivables and inventory.
  5. EBITDA margin compressed due to enhanced marketing schemes for customers.

Good To Know

  1. Aurangabad land is used for seed cultivation and not for sale.
  2. Company registers products under the Plant Varieties Protection Act.
  3. Philippines venture is on hold due to pending government permissions.
  4. Management aims for INR500 crores top line, possibly by next year.

Key Drivers

  1. Strong R&D pipeline for new hybrids.
  2. Expanding international presence via JV.
  3. Government focus on corn for fuel.
  4. Increased water levels aiding Rabi crops.

Key Analyst Discussions

Competitive Environment

  1. Illegal RFF BT cotton negatively impacts the organized seed sector.
  2. GM seeds and tariffs have no correlation; GM cotton was permitted in 2006.
  3. Company is gaining market share in cotton due to strong product performance.
  4. Nath Bio-Genes is preparing for new GM technologies and generating GM crops.

Market Trends & Consumer Behavior

  1. Extended monsoon had minimal impact on farmer cropping patterns.
  2. Bajra volume decline was marginal, expected to improve with government focus.
  3. Maize volume recovery driven by government focus on corn for fuel and stable yields.
  4. Rabi season outlook is positive due to increased water levels from rainfall.
  5. Harsh winters due to La Niña are unpredictable, but company is prepared.

Financial Highlights

  1. Gross profit growth driven by rice, cotton, and maize segments.
  2. EBITDA margin compression attributed to increased marketing schemes.
  3. Working capital expected to normalize as inventory depletes and receivables recover.
  4. Cotton production costs are increasing by 5-10% annually.
  5. H2 FY'26 revenue expected to grow 15%, FY'27 by 15-20%.

Product Composition

  1. Cotton and paddy remain major revenue contributors, expected to be 70-30 H1/H2.
  2. Hybrid paddy accounts for 40-60% of volume and 60-40% of value.
  3. Vegetable segment sales are expected to be positive in the next 5 months.
  4. Plant Nutrition Solutions sales are projected to increase due to farmer benefits.

Strategic Considerations

  1. Strategic initiatives include product innovation, development, and launches.
  2. R&D is an ongoing process, expecting significant product portfolio improvement in 3-4 years.
  3. Key priorities are quality, farmer satisfaction, timely placement, and product mix evolution.
  4. Uzbekistan JV is evaluating products, establishing marketing, and expanding crops.
  5. R&D addresses climate unpredictability through biotic/abiotic stress and heat tolerance programs.